PMC7245658_01
Graph depicting various white cell lines following initiation of immunotherapy (nivolumab) in November 2015.
CRIONM2020-7492634.001.jpg
PMC7245658_01_CRIONM2020-7492634.001.jpg
fig1
Immunotherapy with the checkpoint inhibitor nivolumab was initiated in November 2015 (Figure 1 and Table 1).